[CBO-guideline 'Bacterial meningitis']

J J Roord1, C J Kaandorp,

  • 1Academisch Ziekenhuis Vrije Universiteit, afd. Kindergeneeskunde, Amsterdam.

Insights

Bacterial meningitis is mainly caused by Neisseria meningitidis and Streptococcus pneumoniae. Haemophilus influenzae type b meningitis is rare in the Netherlands due to vaccination, simplifying initial treatment strategies for bacterial meningitis.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Microbiology

Context:

  • Neisseria meningitidis and Streptococcus pneumoniae are primary causes of bacterial meningitis.
  • Haemophilus influenzae type b meningitis incidence is low in the Netherlands due to successful vaccination.
  • Clinical presentation of bacterial meningitis can vary, especially in neonates.

Purpose:

  • To outline current understanding and management of bacterial meningitis.
  • To inform initial empiric antimicrobial therapy decisions.
  • To guide diagnostic procedures like lumbar puncture and CSF examination.

Summary:

  • Acute bacterial meningitis presents with symptoms like fever, headache, stiff neck, and vomiting, though these signs may be absent.
  • Lumbar puncture is crucial for diagnosis in suspected cases, with contraindications including papilledema or focal neurological symptoms pending CT scan.
  • Antibiotic treatment should commence promptly, and CSF re-examination is unnecessary in adequately treated patients.

Impact:

  • Simplifies initial empiric antimicrobial therapy by excluding Haemophilus influenzae type b.
  • Highlights the importance of timely diagnosis and treatment for bacterial meningitis.
  • Provides guidance on lumbar puncture indications and contraindications, and antibiotic management strategies.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...